Pravastatin improves uterine and carotid artery function through vascular bed-specific mechanisms in a rat model of excessive hypercholesterolemia in pregnancy
Clinical Science · 16.11.2026
DOI: 10.1042/cs20261476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 16.11.2026. Verfasst von Amanda A de Oliveira und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Alberta, Edmonton, Canada. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Canadian Institutes of Health Research, Women and Children's Health Research Institute.
Abstract (Originalsprache)
Excessive hypercholesterolemia (eHC) in pregnancy is a risk factor for adverse outcomes, including preeclampsia; however, the underlying mechanisms remain unclear. Uterine artery endothelial dysfunction in eHC is mediated by activation of the toll-like receptor 4 (TLR4)/lectin-like oxidized LDL receptor-1 (LOX-1)/prostaglandin H synthase 1 (PGHS1) pathway. Pravastatin, a cholesterol-lowering drug, reduces the incidence of preeclampsia in high-risk pregnancies due to its pleiotropic effects. Outside of pregnancy, the pleiotropic effects include suppression of TLR4 and LOX-1 signaling. Whether pravastatin improves uterine artery endothelial function in eHC via inhibition of TLR4/LOX-1 is not known. We hypothesized that pravastatin suppresses TLR4/LOX-1 signaling, thereby improving uterine artery endothelial function in eHC pregnancies. Sprague Dawley rats were fed either a control diet or a high cholesterol diet from gestational day (GD) 6-20 and treated with vehicle or pravastatin (5 mg/kg/day) from GD10-20. On GD20, pregnancy outcomes were assessed, and endothelial function in uterine and carotid (a systemic vascular bed that is dysfunctional in postpartum eHC dams) arteries was evaluated using wire myography. In uterine arteries, pravastatin improved blood flow and endothelial function mainly via suppression of TLR4, while also increasing nitric oxide-mediated vasodilation. In carotid arteries, endothelial function was unchanged; however, functional responses to NOS inhibition suggested reduced NO contribution to vasodilation in eHC vehicle-treated dams, accompanied by increased reliance on PGHS2, both of which were normalized in pravastatin-treated dams. These findings demonstrate that pravastatin exerts vascular bed-specific effects and suggest that its use during pregnancy can improve maternal vascular function in eHC pregnancies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Alberta, Edmonton, Canada.
- Univeristy of Alberta, Edmonton, Canada.
Förderung
- Canadian Institutes of Health Research
- Women and Children's Health Research Institute
Zitieren
APA
de Oliveira, A. A., Graton, M. E., Spaans, F., Quon, A., Kirschenman, R., Cooke, C. M., & Davidge, S. T. (2026). Pravastatin improves uterine and carotid artery function through vascular bed-specific mechanisms in a rat model of excessive hypercholesterolemia in pregnancy. Clinical Science. https://doi.org/10.1042/cs20261476
Vancouver
de Oliveira AA, Graton ME, Spaans F, Quon A, Kirschenman R, Cooke CM, et al. Pravastatin improves uterine and carotid artery function through vascular bed-specific mechanisms in a rat model of excessive hypercholesterolemia in pregnancy. Clinical Science. 2026. doi:10.1042/cs20261476
BibTeX
@article{deOliveira2026,
author = {de Oliveira, Amanda A and Graton, Murilo E and Spaans, Floor and Quon, Anita and Kirschenman, Raven and Cooke, Christy-Lynn M and Davidge, Sandra T},
title = {Pravastatin improves uterine and carotid artery function through vascular bed-specific mechanisms in a rat model of excessive hypercholesterolemia in pregnancy},
journal = {Clinical Science},
year = {2026},
doi = {10.1042/cs20261476}
}
EUVIMED